Evidence map›Paper›PMID 40593991›Full record

ArticleScientific reports2025

Preparation and property evaluation of oral colon targeted protein delivery system with sodium alginate and chitosan.

Long Ma, Wentao Zhou, Xizhi Ma, Xiaopo Li, Qian Zhang, Wenting Ma, Nafei Chen, XiaoTao Zhou, XiaoHui Tang

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Immobilization of the Proteolytic Fraction P1G10 fromMolecules (Basel, Switzerland) · 2025
    Article
  4. Chitosan/Alginate-LoadedReproductive medicine and biology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Long Ma *Department of Immunology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi, China.
Wentao Zhou *The Fifth Affiliated Hospital of Xinjiang Medical University, Xinjiang, Urumqi, 830017, China.
Xizhi MaDepartment of Immunology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi, China.
Xiaopo LiDepartment of Immunology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi, China.
Qian ZhangDepartment of Pharmacy, School of Pharmacy, Xinjiang Medical University, Urumqi, 830017, China.
Wenting MaDepartment of Biochemistry and Molecular Biology, Xinjiang Medical University, Urumqi, 830017, China.
Nafei ChenDepartment of Immunology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi, China.
XiaoTao ZhouDepartment of Immunology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi, China. XiaotaoZhou@xjmu.edu.cn.
XiaoHui TangCentral Laboratory of Xinjiang Medical University, Urumqi, 830017, China. Tangxh0429@163.com.

Funding

National Natural Science Foundation of China 32260192,81760656Natural Science Fund of Xinjiang Uygur Autonomous Region 2024D01C90the Outstanding Youth Fund of Xinjiang Autonomous Region 2022D01E50
6 · The paper itself

Abstract

Oral administration of protein-based biologics faces challenges such as low bioavailability and a short half-life in the gastrointestinal tract. This study focuses on developing a novel encapsulation technique using sodium alginate and chitosan to create nanospheres that efficiently deliver bovine serum albumin, a model protein. Through a combination of single-factor and response surface experiments, optimal preparation conditions were identified, yielding stable nanospheres with high encapsulation rates and small particle sizes. The release of the protein was pH-dependent, with more substantial release under alkaline conditions, resembling the environment of the colon. In vitro safety testing confirmed that the nanospheres had low toxicity and did not induce significant hemolysis or cell death. This approach demonstrates significant potential for enhancing the oral bioavailability of protein-based drugs, overcoming the typical challenges faced by oral drug delivery systems. The developed formulation offers a simple yet effective method for targeted colonic delivery, representing a promising strategy for improving the clinical efficiency of protein biologics.

Indexed as

AlginatesChitosanColonDrug CarriersDrug Delivery SystemsSerum Albumin, BovineAdministration, OralAnimalsCattleGlucuronic AcidHexuronic AcidsHumansHydrogen-Ion ConcentrationNanospheresParticle SizeAlginatesChitosanDrug CarriersGlucuronic AcidHexuronic AcidsSerum Albumin, BovineBiosafetyProtein-based biologicsResponse surface experimentsSA-BSA-CSSingle-factor experiment

Identifiers

PMID40593991
PMCPMC12218344

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.